Skip to main content
Top
Published in: Current Treatment Options in Gastroenterology 1/2020

01-03-2020 | Opioids | Esophagus (P Iyer, Section Editor)

Minor esophageal functional disorders: are they relevant?

Authors: Ryan A. Balko, Don C. Codipilly, Karthik Ravi

Published in: Current Treatment Options in Gastroenterology | Issue 1/2020

Login to get access

Abstract

Purpose of review

High resolution esophageal manometry (HRM) has expanded understanding of esophageal motor function. The Chicago Classification scheme has allowed systematic categorization of the myriad of manometric parameters identified during HRM. Multichannel intraluminal impedance pH has enhanced ambulatory reflux monitoring through complete assessment of esophageal content transit. However, the clinical implications of identified minor esophageal functional disorders remain unclear.

Recent findings

Esophagogastric junction outlet obstruction is defined by esophagogastric junction obstruction with preserved peristalsis and may be managed expectantly, or in a manner similar to achalasia. Hypercontractile esophagus has been associated with dysphagia and non-cardiac chest pain, but the clinical significance is unclear as a majority of patients will improve without specific therapy. Additionally, these findings may be confounded by chronic opiate use. Ineffective esophageal motility is characterized by diminished esophageal contraction amplitude, potentially causing dysphagia and GERD. However, this is commonly identified in asymptomatic volunteers and may represent a normal variant. The multiple rapid swallow sequence can assess esophageal contraction reserve, which may predict post fundoplication dysphagia. The post-swallow induced peristaltic wave can serve as a surrogate of gastric refluxate clearance, providing important prognostic value. However, the associated time burden and lack of alternative therapeutic options limit its clinical utility.

Summary

Minor esophageal functional disorders provide new therapeutic targets for symptomatic patients. However, these findings have inconsistent associations with symptoms and poorly defined therapeutic options. Minor esophageal function disorders should not be interpreted in isolation, with management decisions accounting for clinical, endoscopic, and radiographic factors in addition.
Literature
1.
go back to reference Cho SY, Choung RS, Saito YA, Schleck CD, Zinsmeister AR, Locke Iii GR, et al. Prevalence and risk factors for dysphagia: a USA community study. Neurogastroenterol Motil. 2015;27(2):212–9.PubMedCrossRef Cho SY, Choung RS, Saito YA, Schleck CD, Zinsmeister AR, Locke Iii GR, et al. Prevalence and risk factors for dysphagia: a USA community study. Neurogastroenterol Motil. 2015;27(2):212–9.PubMedCrossRef
2.
go back to reference Eusebi LH, Ratnakumaran R, Yuan Y, Solaymani-Dodaran M, Bazzoli F, Ford AC. Global prevalence of, and risk factors for, gastro-oesophageal reflux symptoms: a meta-analysis. Gut. 2018;67(3):430–40.PubMedCrossRef Eusebi LH, Ratnakumaran R, Yuan Y, Solaymani-Dodaran M, Bazzoli F, Ford AC. Global prevalence of, and risk factors for, gastro-oesophageal reflux symptoms: a meta-analysis. Gut. 2018;67(3):430–40.PubMedCrossRef
3.
go back to reference Eslick GD. Classification, natural history, epidemiology, and risk factors of noncardiac chest pain. Disease-a-month : Dis Mon. 2008;54(9):593–603.PubMedCrossRef Eslick GD. Classification, natural history, epidemiology, and risk factors of noncardiac chest pain. Disease-a-month : Dis Mon. 2008;54(9):593–603.PubMedCrossRef
4.
go back to reference Kahrilas PJ, Bredenoord AJ, Fox M, Gyawali CP, Roman S, Smout AJ, et al. The Chicago Classification of esophageal motility disorders, v3.0. Neurogastroenterol Motil. 2015;27(2):160–74.PubMedCrossRef Kahrilas PJ, Bredenoord AJ, Fox M, Gyawali CP, Roman S, Smout AJ, et al. The Chicago Classification of esophageal motility disorders, v3.0. Neurogastroenterol Motil. 2015;27(2):160–74.PubMedCrossRef
5.
go back to reference Perez-Fernandez MT, Santander C, Marinero A, Burgos-Santamaria D, Chavarria-Herbozo C. Characterization and follow-up of esophagogastric junction outflow obstruction detected by high resolution manometry. Neurogastroenterol Motil. 2016;28(1):116–26.PubMedCrossRef Perez-Fernandez MT, Santander C, Marinero A, Burgos-Santamaria D, Chavarria-Herbozo C. Characterization and follow-up of esophagogastric junction outflow obstruction detected by high resolution manometry. Neurogastroenterol Motil. 2016;28(1):116–26.PubMedCrossRef
6.
go back to reference Lynch KL, Yang YX, Metz DC, Falk GW. Clinical presentation and disease course of patients with esophagogastric junction outflow obstruction. Dis Esophagus. 2017;30(6):1–6.PubMedCrossRef Lynch KL, Yang YX, Metz DC, Falk GW. Clinical presentation and disease course of patients with esophagogastric junction outflow obstruction. Dis Esophagus. 2017;30(6):1–6.PubMedCrossRef
7.
go back to reference Triadafilopoulos G, Clarke JO. Clinical and manometric characteristics of patients with oesophagogastric outflow obstruction: towards a new classification. BMJ Open Gastroenterol. 2018;5(1):e000210.PubMedPubMedCentralCrossRef Triadafilopoulos G, Clarke JO. Clinical and manometric characteristics of patients with oesophagogastric outflow obstruction: towards a new classification. BMJ Open Gastroenterol. 2018;5(1):e000210.PubMedPubMedCentralCrossRef
8.
go back to reference • Schupack D, Katzka DA, Geno DM, Ravi K. The clinical significance of esophagogastric junction outflow obstruction and hypercontractile esophagus in high resolution esophageal manometry. Neurogastroenterol Motil. 2017;29(10):e13105 Schupack et al retrospectively reviewed manometry reports of patients with EGJOO and JHE and found these patients typically have a benign course with resolution without specific therapy in the majority.CrossRef • Schupack D, Katzka DA, Geno DM, Ravi K. The clinical significance of esophagogastric junction outflow obstruction and hypercontractile esophagus in high resolution esophageal manometry. Neurogastroenterol Motil. 2017;29(10):e13105 Schupack et al retrospectively reviewed manometry reports of patients with EGJOO and JHE and found these patients typically have a benign course with resolution without specific therapy in the majority.CrossRef
9.
go back to reference van Hoeij FB, Smout AJ, Bredenoord AJ. Characterization of idiopathic esophagogastric junction outflow obstruction. Neurogastroenterol Motil. 2015;27(9):1310–6.PubMedCrossRef van Hoeij FB, Smout AJ, Bredenoord AJ. Characterization of idiopathic esophagogastric junction outflow obstruction. Neurogastroenterol Motil. 2015;27(9):1310–6.PubMedCrossRef
10.
go back to reference Richter JE, Clayton SB. Diagnosis and Management of Esophagogastric Junction Outflow Obstruction. Am J Gastroenterol. 2019;114(4):544–7.PubMedCrossRef Richter JE, Clayton SB. Diagnosis and Management of Esophagogastric Junction Outflow Obstruction. Am J Gastroenterol. 2019;114(4):544–7.PubMedCrossRef
11.
go back to reference Okeke FC, Raja S, Lynch KL, Dhalla S, Nandwani M, Stein EM, et al. What is the clinical significance of esophagogastric junction outflow obstruction? evaluation of 60 patients at a tertiary referral center. Neurogastroenterol Motil. 2017;29(6). Okeke FC, Raja S, Lynch KL, Dhalla S, Nandwani M, Stein EM, et al. What is the clinical significance of esophagogastric junction outflow obstruction? evaluation of 60 patients at a tertiary referral center. Neurogastroenterol Motil. 2017;29(6).
12.
go back to reference Blonski W, Kumar A, Feldman J, Richter JE. Timed barium swallow: diagnostic role and predictive value in untreated achalasia, Esophagogastric junction outflow obstruction, and non-achalasia dysphagia. Am J Gastroenterol. 2018;113(2):196–203.PubMedCrossRef Blonski W, Kumar A, Feldman J, Richter JE. Timed barium swallow: diagnostic role and predictive value in untreated achalasia, Esophagogastric junction outflow obstruction, and non-achalasia dysphagia. Am J Gastroenterol. 2018;113(2):196–203.PubMedCrossRef
13.
go back to reference • Liu A, Woo M, Nasser Y, Gupta M, Buresi MC, Curley M, et al. Esophagogastric junction outflow obstruction on manometry: outcomes and lack of benefit from CT and EUS. Neurogastroenterol Motil. 2019;0(0):e13712 Liu et al demonstrated a lack in change of clinical management in a cohort of 107 EGJOO patients who underwent further testing with CT or EUS, determining that such studies are not necessary in the majority of patients with this condition. • Liu A, Woo M, Nasser Y, Gupta M, Buresi MC, Curley M, et al. Esophagogastric junction outflow obstruction on manometry: outcomes and lack of benefit from CT and EUS. Neurogastroenterol Motil. 2019;0(0):e13712 Liu et al demonstrated a lack in change of clinical management in a cohort of 107 EGJOO patients who underwent further testing with CT or EUS, determining that such studies are not necessary in the majority of patients with this condition.
14.
go back to reference Jung KW, Jung HY, Myung SJ, Kim SO, Lee J, Yoon IJ, et al. The effect of age on the key parameters in the Chicago classification: a study using high-resolution esophageal manometry in asymptomatic normal individuals. Neurogastroenterol Motil. 2015;27(2):246–57.PubMedCrossRef Jung KW, Jung HY, Myung SJ, Kim SO, Lee J, Yoon IJ, et al. The effect of age on the key parameters in the Chicago classification: a study using high-resolution esophageal manometry in asymptomatic normal individuals. Neurogastroenterol Motil. 2015;27(2):246–57.PubMedCrossRef
15.
go back to reference Garbarino S, von Isenburg M, Fisher DA, Leiman DA. Management of functional esophagogastric junction outflow obstruction: a systematic review. J Clin Gastroenterol. 2018. Garbarino S, von Isenburg M, Fisher DA, Leiman DA. Management of functional esophagogastric junction outflow obstruction: a systematic review. J Clin Gastroenterol. 2018.
16.
go back to reference Clayton SB, Patel R, Richter JE. Functional and anatomic Esophagogastic junction outflow obstruction: manometry, timed barium esophagram findings, and treatment outcomes. Clin Gastroenterol Hepatol. 2016;14(6):907–11.PubMedCrossRef Clayton SB, Patel R, Richter JE. Functional and anatomic Esophagogastic junction outflow obstruction: manometry, timed barium esophagram findings, and treatment outcomes. Clin Gastroenterol Hepatol. 2016;14(6):907–11.PubMedCrossRef
17.
go back to reference Porter RF, Gyawali CP. Botulinum toxin injection in dysphagia syndromes with preserved esophageal peristalsis and incomplete lower esophageal sphincter relaxation. Neurogastroenterol Motil. 2011;23(2):139–44 e27-8.PubMedCrossRef Porter RF, Gyawali CP. Botulinum toxin injection in dysphagia syndromes with preserved esophageal peristalsis and incomplete lower esophageal sphincter relaxation. Neurogastroenterol Motil. 2011;23(2):139–44 e27-8.PubMedCrossRef
18.
go back to reference Scherer JR, Kwiatek MA, Soper NJ, Pandolfino JE, Kahrilas PJ. Functional esophagogastric junction obstruction with intact peristalsis: a heterogeneous syndrome sometimes akin to achalasia. J Gastrointest Surg. 2009;13(12):2219–25.PubMedPubMedCentralCrossRef Scherer JR, Kwiatek MA, Soper NJ, Pandolfino JE, Kahrilas PJ. Functional esophagogastric junction obstruction with intact peristalsis: a heterogeneous syndrome sometimes akin to achalasia. J Gastrointest Surg. 2009;13(12):2219–25.PubMedPubMedCentralCrossRef
19.
go back to reference Penagini R, Picone A, Bianchi PA. Effect of morphine and naloxone on motor response of the human esophagus to swallowing and distension. Am J Phys. 1996;271(4 Pt 1):G675–80. Penagini R, Picone A, Bianchi PA. Effect of morphine and naloxone on motor response of the human esophagus to swallowing and distension. Am J Phys. 1996;271(4 Pt 1):G675–80.
20.
go back to reference Mittal RK, Frank EB, Lange RC, McCallum RW. Effects of morphine and naloxone on esophageal motility and gastric emptying in man. Dig Dis Sci. 1986;31(9):936–42.PubMedCrossRef Mittal RK, Frank EB, Lange RC, McCallum RW. Effects of morphine and naloxone on esophageal motility and gastric emptying in man. Dig Dis Sci. 1986;31(9):936–42.PubMedCrossRef
21.
go back to reference Kraichely RE, Arora AS, Murray JA. Opiate-induced oesophageal dysmotility. Aliment Pharmacol Ther. 2010;31(5):601–6.PubMedCrossRef Kraichely RE, Arora AS, Murray JA. Opiate-induced oesophageal dysmotility. Aliment Pharmacol Ther. 2010;31(5):601–6.PubMedCrossRef
22.
go back to reference Ravi K, Murray JA, Geno DM, Katzka DA. Achalasia and chronic opiate use: innocent bystanders or associated conditions? Dis Esophagus. 2016;29(1):15–21.PubMedCrossRef Ravi K, Murray JA, Geno DM, Katzka DA. Achalasia and chronic opiate use: innocent bystanders or associated conditions? Dis Esophagus. 2016;29(1):15–21.PubMedCrossRef
23.
go back to reference Ratuapli SK, Crowell MD, DiBaise JK, Vela MF, Ramirez FC, Burdick GE, et al. Opioid-induced esophageal dysfunction (OIED) in patients on chronic opioids. Am J Gastroenterol. 2015;110(7):979–84.PubMedCrossRef Ratuapli SK, Crowell MD, DiBaise JK, Vela MF, Ramirez FC, Burdick GE, et al. Opioid-induced esophageal dysfunction (OIED) in patients on chronic opioids. Am J Gastroenterol. 2015;110(7):979–84.PubMedCrossRef
24.
go back to reference • Snyder DL, Crowell MD, Horsley-Silva J, Ravi K, Lacy BE, Vela MF. Opioid-induced esophageal dysfunction: differential effects of type and dose. Am J Gastroenterol. 2019;114(9):1464–9 Snyder et al demonstrated a dose dependent association between chronic opiate use and EGJOO and JHE on HRM.PubMedCrossRef • Snyder DL, Crowell MD, Horsley-Silva J, Ravi K, Lacy BE, Vela MF. Opioid-induced esophageal dysfunction: differential effects of type and dose. Am J Gastroenterol. 2019;114(9):1464–9 Snyder et al demonstrated a dose dependent association between chronic opiate use and EGJOO and JHE on HRM.PubMedCrossRef
25.
go back to reference Pandolfino JE, de Ruigh A, Nicodeme F, Xiao Y, Boris L, Kahrilas PJ. Distensibility of the esophagogastric junction assessed with the functional lumen imaging probe (FLIP) in achalasia patients. Neurogastroenterol Motil. 2013;25(6):496–501.PubMedPubMedCentralCrossRef Pandolfino JE, de Ruigh A, Nicodeme F, Xiao Y, Boris L, Kahrilas PJ. Distensibility of the esophagogastric junction assessed with the functional lumen imaging probe (FLIP) in achalasia patients. Neurogastroenterol Motil. 2013;25(6):496–501.PubMedPubMedCentralCrossRef
26.
go back to reference Clement M, Zhu WJ, Neshkova E, Bouin M. Jackhammer esophagus: from manometric diagnosis to clinical presentation. Can J Gastroenterol Hepatol. 2019;2019:5036160.PubMedPubMedCentralCrossRef Clement M, Zhu WJ, Neshkova E, Bouin M. Jackhammer esophagus: from manometric diagnosis to clinical presentation. Can J Gastroenterol Hepatol. 2019;2019:5036160.PubMedPubMedCentralCrossRef
27.
go back to reference Kristo I, Schwameis K, Maschke S, Kainz A, Rieder E, Paireder M, et al. Phenotypes of jackhammer esophagus in patients with typical symptoms of gastroesophageal reflux disease responsive to proton pump inhibitors. Sci Rep. 2018;8(1):9949.PubMedPubMedCentralCrossRef Kristo I, Schwameis K, Maschke S, Kainz A, Rieder E, Paireder M, et al. Phenotypes of jackhammer esophagus in patients with typical symptoms of gastroesophageal reflux disease responsive to proton pump inhibitors. Sci Rep. 2018;8(1):9949.PubMedPubMedCentralCrossRef
28.
go back to reference Kamal A, Shakya S, Lopez R, Thota PN. Gender, medication use and other factors associated with esophageal motility disorders in non-obstructive dysphagia. Gastroenterol Rep (Oxf). 2018;6(3):177–83.CrossRef Kamal A, Shakya S, Lopez R, Thota PN. Gender, medication use and other factors associated with esophageal motility disorders in non-obstructive dysphagia. Gastroenterol Rep (Oxf). 2018;6(3):177–83.CrossRef
29.
go back to reference Huang L, Pimentel M, Rezaie A. Do jackhammer contractions lead to achalasia? A longitudinal study. Neurogastroenterol Motil. 2017;29(3):e12953.CrossRef Huang L, Pimentel M, Rezaie A. Do jackhammer contractions lead to achalasia? A longitudinal study. Neurogastroenterol Motil. 2017;29(3):e12953.CrossRef
30.
go back to reference Kahn A, Al-Qaisi MT, Obeid RA, Katzka DA, Ravi KM, Ramirez FC, et al. Clinical features and long-term outcomes of lower esophageal sphincter-dependent and lower esophageal sphincter-independent jackhammer esophagus. Neurogastroenterol Motil. 2019;31(2):e13507.PubMedCrossRef Kahn A, Al-Qaisi MT, Obeid RA, Katzka DA, Ravi KM, Ramirez FC, et al. Clinical features and long-term outcomes of lower esophageal sphincter-dependent and lower esophageal sphincter-independent jackhammer esophagus. Neurogastroenterol Motil. 2019;31(2):e13507.PubMedCrossRef
31.
go back to reference Al-Qaisi MT, Siddiki HA, Crowell MD, Burdick GE, Fleischer DE, Ramirez FC, et al. The clinical significance of hypercontractile peristalsis: comparison of high-resolution manometric features, demographics, symptom presentation, and response to therapy in patients with jackhammer esophagus versus nutcracker esophagus. Dis Esophagus. 2017;30(12):1–7.PubMedCrossRef Al-Qaisi MT, Siddiki HA, Crowell MD, Burdick GE, Fleischer DE, Ramirez FC, et al. The clinical significance of hypercontractile peristalsis: comparison of high-resolution manometric features, demographics, symptom presentation, and response to therapy in patients with jackhammer esophagus versus nutcracker esophagus. Dis Esophagus. 2017;30(12):1–7.PubMedCrossRef
32.
go back to reference Mion F, Marjoux S, Subtil F, Pioche M, Rivory J, Roman S, et al. Botulinum toxin for the treatment of hypercontractile esophagus: results of a double-blind randomized sham-controlled study. Neurogastroenterol Motil. 2019;31(5):e13587.PubMedCrossRef Mion F, Marjoux S, Subtil F, Pioche M, Rivory J, Roman S, et al. Botulinum toxin for the treatment of hypercontractile esophagus: results of a double-blind randomized sham-controlled study. Neurogastroenterol Motil. 2019;31(5):e13587.PubMedCrossRef
33.
go back to reference Khashab MA, Messallam AA, Onimaru M, Teitelbaum EN, Ujiki MB, Gitelis ME, et al. International multicenter experience with peroral endoscopic myotomy for the treatment of spastic esophageal disorders refractory to medical therapy (with video). Gastrointest Endosc. 2015;81(5):1170–7.PubMedCrossRef Khashab MA, Messallam AA, Onimaru M, Teitelbaum EN, Ujiki MB, Gitelis ME, et al. International multicenter experience with peroral endoscopic myotomy for the treatment of spastic esophageal disorders refractory to medical therapy (with video). Gastrointest Endosc. 2015;81(5):1170–7.PubMedCrossRef
34.
go back to reference Boland K, Abdul-Hussein M, Tutuian R, Castell DO. Characteristics of consecutive esophageal motility diagnoses after a decade of change. J Clin Gastroenterol. 2016;50(4):301–6.PubMedCrossRef Boland K, Abdul-Hussein M, Tutuian R, Castell DO. Characteristics of consecutive esophageal motility diagnoses after a decade of change. J Clin Gastroenterol. 2016;50(4):301–6.PubMedCrossRef
35.
go back to reference Hollenstein M, Thwaites P, Butikofer S, Heinrich H, Sauter M, Ulmer I, et al. Pharyngeal swallowing and oesophageal motility during a solid meal test: a prospective study in healthy volunteers and patients with major motility disorders. Lancet Gastroenterol Hepatol. 2017;2(9):644–53.PubMedCrossRef Hollenstein M, Thwaites P, Butikofer S, Heinrich H, Sauter M, Ulmer I, et al. Pharyngeal swallowing and oesophageal motility during a solid meal test: a prospective study in healthy volunteers and patients with major motility disorders. Lancet Gastroenterol Hepatol. 2017;2(9):644–53.PubMedCrossRef
36.
go back to reference Xiao Y, Kahrilas PJ, Nicodeme F, Lin Z, Roman S, Pandolfino JE. Lack of correlation between HRM metrics and symptoms during the manometric protocol. Am J Gastroenterol. 2014;109(4):521–6.PubMedPubMedCentralCrossRef Xiao Y, Kahrilas PJ, Nicodeme F, Lin Z, Roman S, Pandolfino JE. Lack of correlation between HRM metrics and symptoms during the manometric protocol. Am J Gastroenterol. 2014;109(4):521–6.PubMedPubMedCentralCrossRef
37.
go back to reference Shetler KP, Bikhtii S, Triadafilopoulos G. Ineffective esophageal motility: clinical, manometric, and outcome characteristics in patients with and without abnormal esophageal acid exposure. Dis Esophagus. 2017;30(6):1–8.PubMedCrossRef Shetler KP, Bikhtii S, Triadafilopoulos G. Ineffective esophageal motility: clinical, manometric, and outcome characteristics in patients with and without abnormal esophageal acid exposure. Dis Esophagus. 2017;30(6):1–8.PubMedCrossRef
38.
go back to reference Reddy CA, Baker JR, Lau J, Chen JW. High-resolution manometry diagnosis of ineffective esophageal motility is associated with higher reflux burden. Dig Dis Sci. 2019;64(8):2199–205.PubMedCrossRef Reddy CA, Baker JR, Lau J, Chen JW. High-resolution manometry diagnosis of ineffective esophageal motility is associated with higher reflux burden. Dig Dis Sci. 2019;64(8):2199–205.PubMedCrossRef
39.
go back to reference Ho SC, Chang CS, Wu CY, Chen GH. Ineffective esophageal motility is a primary motility disorder in gastroesophageal reflux disease. Dig Dis Sci. 2002;47(3):652–6.PubMedCrossRef Ho SC, Chang CS, Wu CY, Chen GH. Ineffective esophageal motility is a primary motility disorder in gastroesophageal reflux disease. Dig Dis Sci. 2002;47(3):652–6.PubMedCrossRef
40.
go back to reference Chugh P, Collazo T, Dworkin B, Jodorkovsky D. Ineffective esophageal motility is associated with impaired bolus clearance but does not correlate with severity of dysphagia. Dig Dis Sci. 2019;64(3):811–4.PubMedCrossRef Chugh P, Collazo T, Dworkin B, Jodorkovsky D. Ineffective esophageal motility is associated with impaired bolus clearance but does not correlate with severity of dysphagia. Dig Dis Sci. 2019;64(3):811–4.PubMedCrossRef
41.
go back to reference Yamada T. Motor disorders of the esophagus. Handbook of gastroenterology Philadelphia: Lippincott Williams & Wilkins. 2005:193–203. Yamada T. Motor disorders of the esophagus. Handbook of gastroenterology Philadelphia: Lippincott Williams & Wilkins. 2005:193–203.
42.
go back to reference Jain A, Baker JR, Chen JW. In ineffective esophageal motility, failed swallows are more functionally relevant than weak swallows. Neurogastroenterol Motil. 2018;30(6):e13297.PubMedCrossRef Jain A, Baker JR, Chen JW. In ineffective esophageal motility, failed swallows are more functionally relevant than weak swallows. Neurogastroenterol Motil. 2018;30(6):e13297.PubMedCrossRef
43.
go back to reference Rangan V, George NS, Khan F, Geng Z, Gabbard S, Kichler A, et al. Severity of ineffective esophageal motility is associated with utilization of skeletal muscle relaxant medications. Neurogastroenterol Motil. 2018;30(4):e13235.PubMedCrossRef Rangan V, George NS, Khan F, Geng Z, Gabbard S, Kichler A, et al. Severity of ineffective esophageal motility is associated with utilization of skeletal muscle relaxant medications. Neurogastroenterol Motil. 2018;30(4):e13235.PubMedCrossRef
44.
go back to reference Fibbe C, Layer P, Keller J, Strate U, Emmermann A, Zornig C. Esophageal motility in reflux disease before and after fundoplication: a prospective, randomized, clinical, and manometric study. Gastroenterology. 2001;121(1):5–14.PubMedCrossRef Fibbe C, Layer P, Keller J, Strate U, Emmermann A, Zornig C. Esophageal motility in reflux disease before and after fundoplication: a prospective, randomized, clinical, and manometric study. Gastroenterology. 2001;121(1):5–14.PubMedCrossRef
45.
go back to reference Booth M, Stratford J, Dehn TC. Preoperative esophageal body motility does not influence the outcome of laparoscopic Nissen fundoplication for gastroesophageal reflux disease. Dis Esophagus. 2002;15(1):57–60.PubMedCrossRef Booth M, Stratford J, Dehn TC. Preoperative esophageal body motility does not influence the outcome of laparoscopic Nissen fundoplication for gastroesophageal reflux disease. Dis Esophagus. 2002;15(1):57–60.PubMedCrossRef
46.
go back to reference Munitiz V, Ortiz A, Martinez de Haro LF, Molina J, Parrilla P. Ineffective oesophageal motility does not affect the clinical outcome of open Nissen fundoplication. Br J Surg. 2004;91(8):1010–4.PubMedCrossRef Munitiz V, Ortiz A, Martinez de Haro LF, Molina J, Parrilla P. Ineffective oesophageal motility does not affect the clinical outcome of open Nissen fundoplication. Br J Surg. 2004;91(8):1010–4.PubMedCrossRef
47.
go back to reference Ravi N, Al-Sarraf N, Moran T, O'Riordan J, Rowley S, Byrne PJ, et al. Acid normalization and improved esophageal motility after Nissen fundoplication: equivalent outcomes in patients with normal and ineffective esophageal motility. Am J Surg. 2005;190(3):445–50.PubMedCrossRef Ravi N, Al-Sarraf N, Moran T, O'Riordan J, Rowley S, Byrne PJ, et al. Acid normalization and improved esophageal motility after Nissen fundoplication: equivalent outcomes in patients with normal and ineffective esophageal motility. Am J Surg. 2005;190(3):445–50.PubMedCrossRef
48.
go back to reference Tsereteli Z, Sporn E, Astudillo JA, Miedema B, Eubanks WS, Thaler K. Laparoscopic Nissen fundoplication is a good option in patients with abnormal esophageal motility. Surg Endosc. 2009;23(10):2292–5.PubMedCrossRef Tsereteli Z, Sporn E, Astudillo JA, Miedema B, Eubanks WS, Thaler K. Laparoscopic Nissen fundoplication is a good option in patients with abnormal esophageal motility. Surg Endosc. 2009;23(10):2292–5.PubMedCrossRef
49.
go back to reference Rydberg L, Ruth M, Abrahamsson H, Lundell L. Tailoring antireflux surgery: a randomized clinical trial. World J Surg. 1999;23(6):612–8.PubMedCrossRef Rydberg L, Ruth M, Abrahamsson H, Lundell L. Tailoring antireflux surgery: a randomized clinical trial. World J Surg. 1999;23(6):612–8.PubMedCrossRef
50.
go back to reference Chrysos E, Tsiaoussis J, Zoras OJ, Athanasakis E, Mantides A, Katsamouris A, et al. Laparoscopic surgery for gastroesophageal reflux disease patients with impaired esophageal peristalsis: total or partial fundoplication? J Am Coll Surg. 2003;197(1):8–15.PubMedCrossRef Chrysos E, Tsiaoussis J, Zoras OJ, Athanasakis E, Mantides A, Katsamouris A, et al. Laparoscopic surgery for gastroesophageal reflux disease patients with impaired esophageal peristalsis: total or partial fundoplication? J Am Coll Surg. 2003;197(1):8–15.PubMedCrossRef
51.
go back to reference Booth MI, Stratford J, Jones L, Dehn TC. Randomized clinical trial of laparoscopic total (Nissen) versus posterior partial (Toupet) fundoplication for gastro-oesophageal reflux disease based on preoperative oesophageal manometry. Br J Surg. 2008;95(1):57–63.PubMedCrossRef Booth MI, Stratford J, Jones L, Dehn TC. Randomized clinical trial of laparoscopic total (Nissen) versus posterior partial (Toupet) fundoplication for gastro-oesophageal reflux disease based on preoperative oesophageal manometry. Br J Surg. 2008;95(1):57–63.PubMedCrossRef
52.
go back to reference Broeders JA, Sportel IG, Jamieson GG, Nijjar RS, Granchi N, Myers JC, et al. Impact of ineffective oesophageal motility and wrap type on dysphagia after laparoscopic fundoplication. Br J Surg. 2011;98(10):1414–21.PubMedCrossRef Broeders JA, Sportel IG, Jamieson GG, Nijjar RS, Granchi N, Myers JC, et al. Impact of ineffective oesophageal motility and wrap type on dysphagia after laparoscopic fundoplication. Br J Surg. 2011;98(10):1414–21.PubMedCrossRef
53.
go back to reference • Siegal SR, Dunst CM, Robinson B, Dewey EN, Swanstrom LL, DeMeester SR. Preoperative high-resolution manometry criteria are associated with dysphagia after nissen fundoplication. World J Surg. 2019;43(4):1062–7 Siegal et al. demonstrated that pre-fundoplication manometry was unable to predict which patients would have post-operative dysphagia in a cohort of 94 patients undergoing fundoplication.PubMedCrossRef • Siegal SR, Dunst CM, Robinson B, Dewey EN, Swanstrom LL, DeMeester SR. Preoperative high-resolution manometry criteria are associated with dysphagia after nissen fundoplication. World J Surg. 2019;43(4):1062–7 Siegal et al. demonstrated that pre-fundoplication manometry was unable to predict which patients would have post-operative dysphagia in a cohort of 94 patients undergoing fundoplication.PubMedCrossRef
54.
go back to reference Davis CS, Shankaran V, Kovacs EJ, Gagermeier J, Dilling D, Alex CG, et al. Gastroesophageal reflux disease after lung transplantation: pathophysiology and implications for treatment. Surgery. 2010;148(4):737–44 discussion 44-5.PubMedCrossRef Davis CS, Shankaran V, Kovacs EJ, Gagermeier J, Dilling D, Alex CG, et al. Gastroesophageal reflux disease after lung transplantation: pathophysiology and implications for treatment. Surgery. 2010;148(4):737–44 discussion 44-5.PubMedCrossRef
55.
go back to reference Tangaroonsanti A, Lee AS, Crowell MD, Vela MF, Jones DR, Erasmus D, et al. Impaired esophageal motility and clearance post-lung transplant: risk for chronic allograft failure. Clin Transl Gastroenterol. 2017;8(6):e102.PubMedPubMedCentralCrossRef Tangaroonsanti A, Lee AS, Crowell MD, Vela MF, Jones DR, Erasmus D, et al. Impaired esophageal motility and clearance post-lung transplant: risk for chronic allograft failure. Clin Transl Gastroenterol. 2017;8(6):e102.PubMedPubMedCentralCrossRef
56.
go back to reference Griffin SM, Robertson AG, Bredenoord AJ, Brownlee IA, Stovold R, Brodlie M, et al. Aspiration and allograft injury secondary to gastroesophageal reflux occur in the immediate post-lung transplantation period (prospective clinical trial). Ann Surg. 2013;258(5):705–11 discussion 11-2.PubMedCrossRef Griffin SM, Robertson AG, Bredenoord AJ, Brownlee IA, Stovold R, Brodlie M, et al. Aspiration and allograft injury secondary to gastroesophageal reflux occur in the immediate post-lung transplantation period (prospective clinical trial). Ann Surg. 2013;258(5):705–11 discussion 11-2.PubMedCrossRef
57.
go back to reference Robertson AG, Krishnan A, Ward C, Pearson JP, Small T, Corris PA, et al. Anti-reflux surgery in lung transplant recipients: outcomes and effects on quality of life. Eur Respir J. 2012;39(3):691–7.PubMedCrossRef Robertson AG, Krishnan A, Ward C, Pearson JP, Small T, Corris PA, et al. Anti-reflux surgery in lung transplant recipients: outcomes and effects on quality of life. Eur Respir J. 2012;39(3):691–7.PubMedCrossRef
58.
go back to reference Fisichella PM, Davis CS, Lundberg PW, Lowery E, Burnham EL, Alex CG, et al. The protective role of laparoscopic antireflux surgery against aspiration of pepsin after lung transplantation. Surgery. 2011;150(4):598–606.PubMedCrossRef Fisichella PM, Davis CS, Lundberg PW, Lowery E, Burnham EL, Alex CG, et al. The protective role of laparoscopic antireflux surgery against aspiration of pepsin after lung transplantation. Surgery. 2011;150(4):598–606.PubMedCrossRef
59.
go back to reference Posner S, Finn RT, Shimpi RA, Wood RK, Fisher D, Hartwig MG, et al. Esophageal contractility increases and gastroesophageal reflux does not worsen after lung transplantation. Dis Esophagus. 2019. Posner S, Finn RT, Shimpi RA, Wood RK, Fisher D, Hartwig MG, et al. Esophageal contractility increases and gastroesophageal reflux does not worsen after lung transplantation. Dis Esophagus. 2019.
60.
go back to reference Agrawal A, Hila A, Tutuian R, Mainie I, Castell DO. Bethanechol improves smooth muscle function in patients with severe ineffective esophageal motility. J Clin Gastroenterol. 2007;41(4):366–70.PubMedCrossRef Agrawal A, Hila A, Tutuian R, Mainie I, Castell DO. Bethanechol improves smooth muscle function in patients with severe ineffective esophageal motility. J Clin Gastroenterol. 2007;41(4):366–70.PubMedCrossRef
61.
go back to reference Lee JY, Kim SK, Cho KB, Park KS, Kwon JG, Jung JT, et al. A double-blind, randomized, multicenter clinical trial investigating the efficacy and safety of esomeprazole single therapy versus mosapride and esomeprazole combined therapy in patients with esophageal reflux disease. J Neurogastroenterol Motil. 2017;23(2):218–28.PubMedPubMedCentralCrossRef Lee JY, Kim SK, Cho KB, Park KS, Kwon JG, Jung JT, et al. A double-blind, randomized, multicenter clinical trial investigating the efficacy and safety of esomeprazole single therapy versus mosapride and esomeprazole combined therapy in patients with esophageal reflux disease. J Neurogastroenterol Motil. 2017;23(2):218–28.PubMedPubMedCentralCrossRef
62.
go back to reference Paireder M, Kristo I, Asari R, Jomrich G, Steindl J, Rieder E, et al. Electrical lower esophageal sphincter augmentation in patients with GERD and severe ineffective esophageal motility-a safety and efficacy study. Surg Endosc. 2019. Paireder M, Kristo I, Asari R, Jomrich G, Steindl J, Rieder E, et al. Electrical lower esophageal sphincter augmentation in patients with GERD and severe ineffective esophageal motility-a safety and efficacy study. Surg Endosc. 2019.
63.
go back to reference Sifrim D. Inhibition in the human esophageal body: its role in normal and disordered motility. 1994. Sifrim D. Inhibition in the human esophageal body: its role in normal and disordered motility. 1994.
64.
go back to reference Sifrim D, Jafari J. Deglutitive inhibition, latency between swallow and esophageal contractions and primary esophageal motor disorders. J Neurogastroenterol Motil. 2012;18(1):6–12.PubMedPubMedCentralCrossRef Sifrim D, Jafari J. Deglutitive inhibition, latency between swallow and esophageal contractions and primary esophageal motor disorders. J Neurogastroenterol Motil. 2012;18(1):6–12.PubMedPubMedCentralCrossRef
65.
go back to reference Meyer GW, Gerhardt DC, Castell DO. Human esophageal response to rapid swallowing: muscle refractory period or neural inhibition? Am J Phys. 1981;241(2):G129–36. Meyer GW, Gerhardt DC, Castell DO. Human esophageal response to rapid swallowing: muscle refractory period or neural inhibition? Am J Phys. 1981;241(2):G129–36.
66.
go back to reference Gyawali CP, Roman S, Bredenoord AJ, Fox M, Keller J, Pandolfino JE, et al. Classification of esophageal motor findings in gastro-esophageal reflux disease: conclusions from an international consensus group. Neurogastroenterol Motil. 2017;29(12). Gyawali CP, Roman S, Bredenoord AJ, Fox M, Keller J, Pandolfino JE, et al. Classification of esophageal motor findings in gastro-esophageal reflux disease: conclusions from an international consensus group. Neurogastroenterol Motil. 2017;29(12).
67.
go back to reference Shaker A, Stoikes N, Drapekin J, Kushnir V, Brunt LM, Gyawali CP. Multiple rapid swallow responses during esophageal high-resolution manometry reflect esophageal body peristaltic reserve. Am J Gastroenterol. 2013;108(11):1706–12.PubMedPubMedCentralCrossRef Shaker A, Stoikes N, Drapekin J, Kushnir V, Brunt LM, Gyawali CP. Multiple rapid swallow responses during esophageal high-resolution manometry reflect esophageal body peristaltic reserve. Am J Gastroenterol. 2013;108(11):1706–12.PubMedPubMedCentralCrossRef
68.
go back to reference • Mauro A, Savarino E, De Bortoli N, Tolone S, Pugliese D, Franchina M, et al. Optimal number of multiple rapid swallows needed during high-resolution esophageal manometry for accurate prediction of contraction reserve. Neurogastroenterol Motil. 2018;30(4):e13253 Mauro et al. studied 159 patients undergoing manometry and demonstrated that 3 MRS sequences are needed to accurately assess the contraction reserve.PubMedCrossRef • Mauro A, Savarino E, De Bortoli N, Tolone S, Pugliese D, Franchina M, et al. Optimal number of multiple rapid swallows needed during high-resolution esophageal manometry for accurate prediction of contraction reserve. Neurogastroenterol Motil. 2018;30(4):e13253 Mauro et al. studied 159 patients undergoing manometry and demonstrated that 3 MRS sequences are needed to accurately assess the contraction reserve.PubMedCrossRef
69.
go back to reference Carlson DA, Crowell MD, Kimmel JN, Patel A, Gyawali CP, Hinchcliff M, et al. Loss of peristaltic reserve, determined by multiple rapid swallows, is the most frequent esophageal motility abnormality in patients with systemic sclerosis. Clin Gastroenterol Hepatol. 2016;14(10):1502–6.PubMedPubMedCentralCrossRef Carlson DA, Crowell MD, Kimmel JN, Patel A, Gyawali CP, Hinchcliff M, et al. Loss of peristaltic reserve, determined by multiple rapid swallows, is the most frequent esophageal motility abnormality in patients with systemic sclerosis. Clin Gastroenterol Hepatol. 2016;14(10):1502–6.PubMedPubMedCentralCrossRef
70.
go back to reference Martinucci I, Savarino EV, Pandolfino JE, Russo S, Bellini M, Tolone S, et al. Vigor of peristalsis during multiple rapid swallows is inversely correlated with acid exposure time in patients with NERD. Neurogastroenterol Motil. 2016;28(2):243–50.PubMedCrossRef Martinucci I, Savarino EV, Pandolfino JE, Russo S, Bellini M, Tolone S, et al. Vigor of peristalsis during multiple rapid swallows is inversely correlated with acid exposure time in patients with NERD. Neurogastroenterol Motil. 2016;28(2):243–50.PubMedCrossRef
71.
go back to reference Helm JF, Dodds WJ, Pelc LR, Palmer DW, Hogan WJ, Teeter BC. Effect of esophageal emptying and saliva on clearance of acid from the esophagus. N Engl J Med. 1984;310(5):284–8.PubMedCrossRef Helm JF, Dodds WJ, Pelc LR, Palmer DW, Hogan WJ, Teeter BC. Effect of esophageal emptying and saliva on clearance of acid from the esophagus. N Engl J Med. 1984;310(5):284–8.PubMedCrossRef
72.
go back to reference Shafik A, El-Sibai O, Shafik AA, Mostafa R. Effect of topical esophageal acidification on salivary secretion: identification of the mechanism of action. J Gastroenterol Hepatol. 2005;20(12):1935–9.PubMedCrossRef Shafik A, El-Sibai O, Shafik AA, Mostafa R. Effect of topical esophageal acidification on salivary secretion: identification of the mechanism of action. J Gastroenterol Hepatol. 2005;20(12):1935–9.PubMedCrossRef
73.
go back to reference Frazzoni M, Manta R, Mirante VG, Conigliaro R, Frazzoni L, Melotti G. Esophageal chemical clearance is impaired in gastro-esophageal reflux disease – a 24-h impedance-pH monitoring assessment. Neurogastroenterol Motil. 2013;25(5):399–e295.PubMedCrossRef Frazzoni M, Manta R, Mirante VG, Conigliaro R, Frazzoni L, Melotti G. Esophageal chemical clearance is impaired in gastro-esophageal reflux disease – a 24-h impedance-pH monitoring assessment. Neurogastroenterol Motil. 2013;25(5):399–e295.PubMedCrossRef
74.
go back to reference Frazzoni M, Savarino E, de Bortoli N, Martinucci I, Furnari M, Frazzoni L, et al. Analyses of the post-reflux swallow-induced peristaltic wave index and nocturnal baseline impedance parameters increase the diagnostic yield of impedance-pH monitoring of patients with reflux disease. Clin Gastroenterol Hepatol. 2016;14(1):40–6.PubMedCrossRef Frazzoni M, Savarino E, de Bortoli N, Martinucci I, Furnari M, Frazzoni L, et al. Analyses of the post-reflux swallow-induced peristaltic wave index and nocturnal baseline impedance parameters increase the diagnostic yield of impedance-pH monitoring of patients with reflux disease. Clin Gastroenterol Hepatol. 2016;14(1):40–6.PubMedCrossRef
75.
go back to reference • Frazzoni L, Frazzoni M, de Bortoli N, Tolone S, Furnari M, Martinucci I, et al. Postreflux swallow-induced peristaltic wave index and nocturnal baseline impedance can link PPI-responsive heartburn to reflux better than acid exposure time. Neurogastroenterol Motil. 2017;29(11). Frazzoni et al studied 425 patients and found that the PSPW is a better predictor of PPI-responsive GERD than acid exposure time • Frazzoni L, Frazzoni M, de Bortoli N, Tolone S, Furnari M, Martinucci I, et al. Postreflux swallow-induced peristaltic wave index and nocturnal baseline impedance can link PPI-responsive heartburn to reflux better than acid exposure time. Neurogastroenterol Motil. 2017;29(11). Frazzoni et al studied 425 patients and found that the PSPW is a better predictor of PPI-responsive GERD than acid exposure time
76.
go back to reference Frazzoni M, Frazzoni L, Tolone S, De Bortoli N, Savarino V, Savarino E. Lack of improvement of impaired chemical clearance characterizes PPI-refractory reflux-related heartburn. Am J Gastroenterol. 2018;113(5):670–6.PubMedCrossRef Frazzoni M, Frazzoni L, Tolone S, De Bortoli N, Savarino V, Savarino E. Lack of improvement of impaired chemical clearance characterizes PPI-refractory reflux-related heartburn. Am J Gastroenterol. 2018;113(5):670–6.PubMedCrossRef
77.
go back to reference Cho YK, Lee JS, Lee TH, Hong SJ, Park SJ, Jeon SR, et al. The relationship of the post-reflux swallow-induced peristaltic wave index and esophageal baseline impedance with gastroesophageal reflux disease symptoms. J Neurogastroenterol Motil. 2017;23(2):237–44.PubMedPubMedCentralCrossRef Cho YK, Lee JS, Lee TH, Hong SJ, Park SJ, Jeon SR, et al. The relationship of the post-reflux swallow-induced peristaltic wave index and esophageal baseline impedance with gastroesophageal reflux disease symptoms. J Neurogastroenterol Motil. 2017;23(2):237–44.PubMedPubMedCentralCrossRef
78.
go back to reference Frazzoni M, Penagini R, Frazzoni L, de Bortoli N, Mauro A, Tolone S, et al. Role of reflux in the pathogenesis of eosinophilic esophagitis: comprehensive appraisal with off- and on PPI impedance-pH monitoring. Am J Gastroenterol 2019. Frazzoni M, Penagini R, Frazzoni L, de Bortoli N, Mauro A, Tolone S, et al. Role of reflux in the pathogenesis of eosinophilic esophagitis: comprehensive appraisal with off- and on PPI impedance-pH monitoring. Am J Gastroenterol 2019.
Metadata
Title
Minor esophageal functional disorders: are they relevant?
Authors
Ryan A. Balko
Don C. Codipilly
Karthik Ravi
Publication date
01-03-2020
Publisher
Springer US
Published in
Current Treatment Options in Gastroenterology / Issue 1/2020
Print ISSN: 1092-8472
Electronic ISSN: 1534-309X
DOI
https://doi.org/10.1007/s11938-020-00279-x

Other articles of this Issue 1/2020

Current Treatment Options in Gastroenterology 1/2020 Go to the issue

Pancreas (V Chandrasekhara, Section Editor)

Molecular Diagnostics and Testing for Pancreatic Cysts

Stomach (P Malfertheiner, Section Editor)

Burden of Gastroduodenal Diseases from the Global Perspective

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.